Loading research…
Ark Genomic Revolution Ucits ETF AccumUSD (SIX: ARKG)
Ark Genomic Revolution Ucits ETF AccumUSD is listed on SIX under the symbol ARKG. This listing is quoted in CHF. The issuer is ARK Investment Management LP. Its asset class is equity. The stated benchmark is No Underlying Index. Review available holdings, fees and performance below. Figures retain their observation dates and currencies.
Fund profile
- Exchange
- SIX
- Trading currency
- CHF
- Issuer
- ARK Investment Management LP
- Brand
- ARK
- Asset class
- Equity
- Category
- Sector
- Investment focus
- Theme
- Strategy
- Active
- Benchmark
- No Underlying Index
- Domicile
- Ireland
- Holdings region
- Global
- ISIN
- IE000O5M6XO1
- FIGI
- BBG01MDGZTF2
- Security classification
- CEOGES
- Inception date
- 2024-04-12
- UCITS compliance
- Compliant
Data notes
Scores, valuation models and research metrics use dated FOLITIC research. Dates and currencies remain attached to their observations. Missing values are shown as a dash.
Market quotes and charts use the separate market-data display. Saved research prices and model comparisons are not live quotes. Model ranges represent sensitivity scenarios, not confidence intervals or price guarantees.
Listings on different exchanges and different share classes are kept separate. No currency conversion is applied to saved research values.